{"count": 3, "results": [{"_id": "32048246", "pmid": 32048246, "title": "Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period.", "journal": "Pharmacol Rep", "authors": ["Sanadgol N", "Barati M", "Houshmand F", "Hassani S", "Clarner T", "Shahlaei M", "Golab F"], "date": "2020-06-01T00:00:00Z", "doi": "10.1007/s43440-019-00019-8", "meta_date_publication": "2020 Jun", "meta_volume": "72", "meta_issue": "3", "meta_pages": "641-658", "score": 50243.523, "text_hl": "Moreover, we observed a significant elevation in the antioxidant responses, especially in mature OLGs (@GENE_MOG @GENE_17441 @@@MOG@@@+/@GENE_NFE2L2 @GENE_18024 @@@nuclear factor erythroid 2-related factor 2@@@ (@GENE_NFE2L2 @GENE_18024 @@@Nrf2@@@+) cells) after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ intervention. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ also reduced brain apoptosis markers and lessened @<m>DISEASE_Motor_Disorders</m> @DISEASE_MESH:D000068079 @@@motor dysfunction@@@ in the open-field test. ", "citations": {"NLM": "Sanadgol N, Barati M, Houshmand F, Hassani S, Clarner T, Shahlaei M, Golab F. Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period. Pharmacol Rep. 2020 Jun;72(3):641-658. PMID: 32048246", "BibTeX": "@article{32048246, title={Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period.}, author={Sanadgol N and Barati M and Houshmand F and Hassani S and Clarner T and Shahlaei M and Golab F}, journal={Pharmacol Rep}, volume={72}, number={3}, pages={641-658}}"}}, {"_id": "34890997", "pmid": 34890997, "title": "Metformin and fluoxetine improve depressive-like behavior in a murine model of Parkinsons disease through the modulation of neuroinflammation, neurogenesis and neuroplasticity.", "journal": "Int Immunopharmacol", "authors": ["Mendonça IP", "Paiva IHR", "Duarte-Silva EP", "Melo MG", "Silva RSD", "Oliveira WH", "Costa BLDSAD", "Peixoto CA"], "date": "2022-01-01T00:00:00Z", "doi": "10.1016/j.intimp.2021.108415", "meta_date_publication": "2022 Jan", "meta_volume": "102", "meta_issue": "", "meta_pages": "108415", "score": 50242.887, "text_hl": "Hippocampus, prefrontal cortex, and substantia nigra were dissected for molecular and morphological analysis. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Fluoxetine @CHEMICAL_MESH:D005473 @@@fluoxetine@@@ prevented @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depressive@@@-like behavior and improved @<m>DISEASE_Motor_Disorders</m> @DISEASE_MESH:D000068079 @@@motor impairment@@@ and increased @GENE_TH @GENE_21823 @@@TH@@@ nigral positive cells. ", "citations": {"NLM": "Mendonça IP, Paiva IHR, Duarte-Silva EP, Melo MG, Silva RSD, Oliveira WH, Costa BLDSAD, Peixoto CA. Metformin and fluoxetine improve depressive-like behavior in a murine model of Parkinsons disease through the modulation of neuroinflammation, neurogenesis and neuroplasticity. Int Immunopharmacol. 2022 Jan;102():108415. PMID: 34890997", "BibTeX": "@article{34890997, title={Metformin and fluoxetine improve depressive-like behavior in a murine model of Parkinsons disease through the modulation of neuroinflammation, neurogenesis and neuroplasticity.}, author={Mendonça IP and Paiva IHR and Duarte-Silva EP and Melo MG and Silva RSD and Oliveira WH and Costa BLDSAD and Peixoto CA}, journal={Int Immunopharmacol}, volume={102}, pages={108415}}"}}, {"_id": "27207919", "pmid": 27207919, "pmcid": "PMC5043649", "title": "Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance", "journal": "Int J Neuropsychopharmacol", "authors": ["Lu M", "Su C", "Qiao C", "Bian Y", "Ding J", "Hu G"], "date": "2016-09-21T00:00:00Z", "doi": "10.1093/ijnp/pyw047", "meta_date_publication": "2016 Sep", "meta_volume": "19", "meta_issue": "9", "meta_pages": "", "score": 50043.832, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Improves @<m>DISEASE_Motor_Disorders</m> @DISEASE_MESH:D000068079 @@@Motor Impairment@@@ and Increases @CHEMICAL_Dopamine @CHEMICAL_MESH:D004298 @@@Dopamine@@@ Level in the Striatum of @CHEMICAL_1_Methyl_4_phenyl_1_2_3_6_tetrahydropyridine @CHEMICAL_MESH:D015632 @@@MPTP@@@/ p @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@PD@@@ Mice", "citations": {"NLM": "Lu M, Su C, Qiao C, Bian Y, Ding J, Hu G. Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance Int J Neuropsychopharmacol. 2016 Sep;19(9):. PMID: 27207919", "BibTeX": "@article{27207919, title={Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance}, author={Lu M and Su C and Qiao C and Bian Y and Ding J and Hu G}, journal={Int J Neuropsychopharmacol}, volume={19}, number={9}}"}}]}